Unknown

Dataset Information

Persistent neuropathy among early-stage breast cancer survivors in a population-based cohort.


ABSTRACT:

Background

The prevalence of persistent peripheral neuropathy (PN) in early-stage breast cancer (ESBC) survivors is largely unknown. We explored the occurrence and risk factors of PN among long-term ESBC survivors treated with taxane chemotherapy.

Methods

A population-based cohort of 884 recurrence-free ESBC survivors diagnosed 2010-2015 in the South East Health Care region, Sweden and 1768 control women without prior cancer received a postal questionnaire that included the European Organisation for Research and Treatment of Cancer chemotherapy-induced peripheral neuropathy (CIPN20) items. Prevalence, relative risks (RRs) (Poisson regression) and risk factors (binomial regression) were calculated. Adjustments were made for confounding factors (e.g. age, body mass index, como

SUBMITTER: Engvall K 

PROVIDER: S-EPMC8329002 | biostudies-literature | 2021 Aug

REPOSITORIES: biostudies-literature